U.S. biotech firm Moderna will build a new research and manufacturing centre in Britain to develop vaccines against new COVID-19 variants, other respiratory illnesses...
Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate...
The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today...
Illumina, Inc. today announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal...
A drug once hailed as Japan's biggest contribution in the global fight against COVID-19 suffered another setback, as Fujifilm Holdings Corp said it was...
AstraZeneca and Merck reported today, Lynparza (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative...